glp 3 retatrutide (GLP3-R) Research Peptide Triple G pen 20 mg

The conventional Ozempic (semaglutide) is a drug that acts only on this GLP-1 receptor

Lactobacillus gasseri Lactobacillus gasseri has been studied for body composition rather than GLP-1 directly

Availability and Manufacturing Status Novo Nordisk has stated that oral Wegovy will be available in pharmacies and through select telehealth platforms in early January 2026

Potential UK Access Pathways Once approved, UK access may follow several routes: NHS specialist weight-management pathways diabetes and metabolic clinics private UK weight-loss clinics licensed prescribers online medical services via regulated telehealth Because the retatrutide peptide targets three metabolic pathways, NHS evaluation may prioritize individuals with severe obesity or strong medical need